Conducting radiogenomic research - Do not forget careful consideration of the clinical data

Radiotherapy and Oncology

Volumn 105, Issue 3, 2012, Pages 337-340

  Andreassen, Christian Nicolaj ^a   Barnett, Gillian C ^b   Langendijk, Johannes A ^c   Alsner, Jan ^a   De Ruysscher, Dirk ^d   Krause, Mechtild ^e   Bentzen, Soren M ^f   Haviland, Joanne S ^g   Griffin, Clare ^g   Poortmans, Philip ^h   Yarnold, John R ^g  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^f UNIVERSITY OF WISCONSIN MADISON   (United States)

^g INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^h DR BERNARD VERBEETEN INSTITUTE   (Netherlands)

Author keywords

Normal tissue radiosensitivity; Predictive markers; Single nucleotide polymorphisms

Indexed keywords

ARTICLE; BLADDER CANCER; BLADDER DISEASE; BREAST CANCER; CANCER RADIOTHERAPY; DIARRHEA; DOSIMETRY; DYSPHAGIA; DYSPNEA; ERECTILE DYSFUNCTION; GENETIC ASSOCIATION; GENOMICS; GENOTYPE; GYNECOLOGIC CANCER; HEAD AND NECK CANCER; HIGH THROUGHPUT SEQUENCING; HUMAN; MEDICAL RESEARCH; MUCOSA INFLAMMATION; NEOPLASM; PHENOTYPE; PRIORITY JOURNAL; PROCTITIS; PROSTATE CANCER; QUALITY OF LIFE; RADIATION INJURY; RADIOGENOMIC; RADIOLOGY; RECTUM HEMORRHAGE; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN FIBROSIS; TELANGIECTASIA;

BIOMEDICAL RESEARCH; EVIDENCE-BASED MEDICINE; GENOMICS; GENOTYPE; HUMANS; NEOPLASMS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84871191017     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.11.004     Document Type: Article

References (27)

1. C.N. Andreassen, E. Dikomey, M. Parliament, and C.M. West Will SNPs be useful predictors of normal tissue radiosensitivity in the future? Radiother Oncol 105 2012 283 288
2. L. Fachal, A. Gomez-Caamano, and P. Peleteiro Association of a XRCC3 polymorphism and rectum mean dose with the risk of acute radio-induced gastrointestinal toxicity in prostate cancer patients Radiother Oncol 105 2012 321 328
3. G.C. Barnett, C.M. West, and A.M. Dunning Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype Nat Rev Cancer 9 2009 134 142
4. C.N. Andreassen Searching for genetic determinants of normal tissue radiosensitivity - are we on the right track? Radiother Oncol 97 2010 1 8
5. G.C. Barnett, C.E. Coles, and R.M. Elliott Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study Lancet Oncol 13 2012 65 77
6. C.J. Talbot, G.A. Tanteles, and G.C. Barnett A replicated association between polymorphisms near TNF-alpha and risk for adverse reactions to radiotherapy Br J Cancer 107 2012 748 753
7. G.C. Barnett, C.E. Coles, and N.G. Burnet No association between SNPs regulating TGF-beta1 secretion and late radiotherapy toxicity to the breast: results from the RAPPER study Radiother Oncol 97 2010 9 14
8. A.Y. Ho, D.P. Atencio, and S. Peters Genetic predictors of adverse radiotherapy effects: the Gene-PARE project Int J Radiat Oncol Biol Phys 65 2006 646 655 (Pubitemid 43795849)
9. D. De Ruysscher, D. Severin, and E. Barnes First report on the patient database for the identification of the genetic pathways involved in patients over-reacting to radiotherapy: GENEPI-II Radiother Oncol 97 2010 36 39
10. C. West, and B.S. Rosenstein Establishment of a radiogenomics consortium Radiother Oncol 94 2010 117 118
11. G.C. Barnett, R.M. Elliott, and J. Alsner Individual patient data meta-analysis shows no association between a SNP regulating TGF-beta 1 secretion and late radiotherapy toxicity Radiother Oncol 105 2012 289 295
12. S.L. Kerns, H. Ostrer, and R. Stock Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer Int J Radiat Oncol Biol Phys 78 2010 1292 1300
13. C.M. West, A.M. Dunning, and B.S. Rosenstein Genome-wide association studies and prediction of normal tissue toxicity Semin Radiat Oncol 22 2012 91 99
14. H.P. Rodemann, and B.G. Wouters Frontiers in molecular radiation biology/oncology Radiother Oncol 101 2011 1 6
15. S.M. Bentzen, H.D. Thames, and M. Overgaard Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study Radiother Oncol 15 1989 267 274 (Pubitemid 19193919)
16. G.C. Barnett, C.M. West, and C.E. Coles Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies Int J Radiat Oncol Biol Phys 82 2012 1065 1074
17. S.M. Bentzen, M. Parliament, and J.O. Deasy Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects Int J Radiat Oncol Biol Phys 76 2010 S145 S150
18. C.N. Andreassen Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 44 2005 801 815 (Pubitemid 41780105)
19. S.M. Bentzen, and M. Overgaard Relationship between early and late normal-tissue injury after postmastectomy radiotherapy Radiother Oncol 20 1991 159 165
20. S.M. Bentzen, M. Overgaard, and J. Overgaard Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity Eur J Cancer 29A 1993 1373 1376 (Pubitemid 23195374)
21. G.C. Barnett, J.S. Wilkinson, and A.M. Moody The Cambridge Breast Intensity-modulated Radiotherapy Trial: patient- and treatment-related factors that influence late toxicity Clin Oncol (R Coll Radiol) 23 2011 662 673
22. C.N. Andreassen, J. Alsner, and J. Overgaard Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it? Radiother Oncol 64 2002 131 140 (Pubitemid 35247890)
23. S.M. Bentzen Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology Nat Rev Cancer 6 2006 702 713 (Pubitemid 44286002)
24. S.M. Bentzen, L.S. Constine, and J.O. Deasy Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues Int J Radiat Oncol Biol Phys 76 2010 S3 S9
25. M.E. Christianen, C. Schilstra, and I. Beetz Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study Radiother Oncol 105 2012 107 114
26. K.R. Trott, W. Doerr, and A. Facoetti Biological mechanisms of normal tissue damage: importance for the design of NTCP models Radiother Oncol 105 2012 79 85
27. N. Andratschke, J. Maurer, M. Molls, and K.R. Trott Late radiation-induced heart disease after radiotherapy. Clinical importance, radiobiological mechanisms and strategies of prevention Radiother Oncol 100 2011 160 166